1. Introduction {#sec1}
===============

Osteocalcin (OC) is involved in bone regeneration. However, the role of F-box and WD-40 domain-containing protein 2 (FBXW2) is unknown. Paraffin sections of bovine periosteum were prepared after 5 weeks of culture. Immunostaining confirmed that OC and FBXW2 are expressed in the bovine periosteum. However, the relationship between these proteins is unclear. Double immunostaining showed that FBXW2 has a tubular structure and that OC is present on the perimeter of FBXW2-containing tubes. This study suggests that FBXW2 localizes with OC on culture dishes.

F-box proteins promote the ubiquitin-proteasome system ([@bib12]; [@bib20]; [@bib24]; [@bib27]; [@bib29]; [@bib32]; [@bib34]) and interact with cell cycle progression ([@bib21]; [@bib33]). One F-box protein, FBXW2, has been identified as a housekeeping gene ([@bib6]), but the functions of FBXW2 are largely unknown. FBXW2 is expressed in placenta cells ([@bib7]; [@bib30]) and lung cancer cell lines and tissue ([@bib31]). A combination of mass spectrometry and immunohistochemistry has been used to analyze proteins expressed in periosteum tissue and cultured periosteum-derived cells, and FBXW2 expression has been confirmed along with other proteins ([@bib1], [@bib2], [@bib3]). A previous study by Akiyama showed that FBXW2 is expressed in periosteum tissue ([@bib3]). Periosteum tissue and cultured periosteum-derived cells are known to possess osteogenic ability ([@bib18]; [@bib25]), and they have been studied in bone regeneration ([@bib5]; [@bib4]). The histology of the periosteum has been widely studied ([@bib8]; [@bib9]; [@bib10]; [@bib16]; [@bib22]) as either the periosteum in living bodies or immediately fixed tissue after death. Additionally, [@bib3] studied periosteum tissue containing periosteum-derived cells after 5 weeks of culture on dishes.

Immunohistochemistry was previously performed using single staining ([@bib1], [@bib2], [@bib3]), but immunostaining using more than one antibody in the same tissue has been used to characterize protein interactions ([@bib13]; [@bib23]). In this study, double immunohistochemistry was performed in order to determine the potential interaction between OC and FBXW2. The findings showed that both FBWX2 and OC were expressed in periosteum tissue. Furthermore, OC appeared to coat FBWX2 tubes.

2. Materials and methods {#sec2}
========================

2.1. Periosteum extraction and section preparation {#sec2.1}
--------------------------------------------------

Periosteum tissue and sections were obtained as described previously ([@bib2]). The periosteum was removed from bovine legs (Kobe Chuo Chikusan, Kobe, Japan) at 24 h after death. All protocols were approved by Osaka Dental University animal experiments committee (approval number 17-02015) and complied with fundamental guidelines for proper conduct of animal experiment and related activities in academic research institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology (the Ministry of Education, Culture, Sports, Science and Technology directive 2006, Notice No. 71). To obtain periosteum-derived cells, the periosteum was used for explant culture on dishes with 10 ml Medium 199 (Gibco by Life Technologies, Grand Island, NY, USA) supplemented with ascorbic acid for 5 weeks. Both the periosteum and periosteum-derived cells were fixed in 4% paraformaldehyde, and paraffin blocks were prepared.

2.2. Double immunostaining {#sec2.2}
--------------------------

Three primary antibodies were used: anti-FBXW2 antibody (1:100, ab5309; Abcam, Cambridge, UK), anti-exosome complex component RRP45 (EXOSC9) (1:200, H-300 for 300 human amino acids; sc-135118; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), and anti-osteocalcin (1:500, code no. M042, clone no. OCG2; Takara Bio Inc., Otsu, Japan). Anti-human procollagen type 1 c-peptide (PIP) (1:500, code no. M011, clone no. PC5-5; Takara Bio Inc.) and anti-Rho GTPase activating protein 36 (ARHGAP36) (1:100, D-14; sc-138596; Santa Cruz Biotechnology, Inc.) were used as negative controls. Anti-EXOSC9 antibody was reported to stain cell nuclei of bovine periosteum-derived cells ([@bib2]). Three secondary antibodies were used: mouse anti-goat IgG-AP (1:200, sc-2355; Santa Cruz Biotechnology, Inc.) with anti-FBXW2 antibody; N-Histofine Simple Stain AP (R) (\#414251, Nichirei Biosciences Inc., Tokyo, Japan) with anti-EXOSC9, and N-Histofine Simple Stain AP (M) (\#414241, Nichirei Biosciences Inc.) with anti-osteocalcin. PermaRed/AP (Diagnostic BioSystems, Pleasanton, CA, USA) and PermaBlue/AP (Diagnostic BioSystems) were used for visualization. Antigens in sections were activated with proteinase K (Dako Cytomation, Glostrup, Denmark).

Four double immunostaining procedures were carried out:A.OC (blue) + EXOSC9 (red)B.PIP (negative control; blue) + EXOSC9 (red)C.OC (red) + FBXW2 (blue)D.OC (red) + no FBXW2 (antibody diluent; blue)

Single immunostaining with FBXW2 was performed as previously described ([@bib3]) and stained with 3,3′-diaminobenzidine tetrahydrochloride (DAB; brown color). ARHGAP36 was set as a negative control of FBXW2 immunostaining. Finally, hematoxylin counterstaining was performed.

3. Results {#sec3}
==========

Akiyama reported that FBXW2 is expressed in the bovine periosteum ([@bib3]) and recently found that FBXW2 forms tubular structures ([Fig. 1](#fig1){ref-type="fig"}a). The diameter of the tubular structures (arrows) was 1--2 microns. While FBXW2 expression was distinct in the periosteum after 5 weeks of culture ([Fig. 1](#fig1){ref-type="fig"}a), FBXW2 expression in bone and periosteum on day 0 was faint ([Fig. 1](#fig1){ref-type="fig"}b, c). Tubular structures were restricted to between the bone and periosteum, and parts of the tubular structure entered into the bone from the periosteum ([Fig. 1](#fig1){ref-type="fig"}b, c). FBXW2 peptide blocked reaction ([Fig. 1](#fig1){ref-type="fig"}d, e). [Figure 2](#fig2){ref-type="fig"}a, b shows a comparison of OC and FBXW2 staining. In [Fig. 2](#fig2){ref-type="fig"}a, double immunostaining of OC (blue) and EXOSC9 (red) coincidentally revealed areas of dense OC expression (arrows) and widespread OC expression in the periosteum. As both OC and FBXW2 were expressed in the periosteum, the relationship between OC and FBXW2 was subsequently investigated. In [Fig. 2](#fig2){ref-type="fig"}b, double immunostaining of OC (red) and FBXW2 (blue) revealed similar localization patterns for OC and FBXW2. [Fig. 3](#fig3){ref-type="fig"}a (condition A) shows outlined tubular structures of OC (blue). [Fig. 3](#fig3){ref-type="fig"}b (condition B) shows PIP (blue) did not form tubular structures. In [Figure 3](#fig3){ref-type="fig"}a, b EXOSC9 (red) expression was observed in periosteum cell nuclei. [Figure 4](#fig4){ref-type="fig"}a--d shows the comparison of OC and FBXW2 localization. [Figure 4](#fig4){ref-type="fig"}a, c (condition C) showed that OC (red) is present on the perimeter of tubular structures of FBXW2 (blue). [Figure 4](#fig4){ref-type="fig"}b, d (condition D) showed that, because OC was thinly deposited, OC expression in condition C was indistinct. ARHGAP36 did not form tubular-shaped structures ([Fig. 4](#fig4){ref-type="fig"}e).Fig. 1(a) FBXW2 in bovine periosteum after 5 weeks of culture with periosteum-derived cells. FBXW2 immunostaining was previously reported in 2016 ([@bib3]), but Fig. 1a is a unique image. (b) FBXW2 in bovine bone (day 0), (c) FBXW2 in bovine periosteum (day 0), (d) with FBXW2 antibody, (e) with FBXW2 peptide. Arrows: tubular structure of FBXW2, B: bone, P: periosteum. Scale bar: 100 μm.Fig. 1Fig. 2Comparison of OC and FBXW2 localization. Both OC and FBXW2 showed similar staining patterns. Arrows: OC.Fig. 2Fig. 3(a, b) Double immunostaining under conditions A and B. (a) OC: blue + EXOSC9: red. (b). PIP (negative control): blue + EXOSC9: red. Scale bar: 100 μm.Fig. 3Fig. 4(a--e) Double immunostaining under conditions C and D. (a, c) OC: red + FBXW2: blue. (b, d) OC: red + no FBXW2: blue. (e) ARHGAP36 (negative control). Scale bar: 100 μm.Fig. 4

4. Discussion {#sec4}
=============

In this study, the potential interaction between OC and FBXW2 were investigated using double immunostaining. The host species of antibodies against OC, EXOSC9, and FBXW2 are mouse, rabbit, and goat, respectively, which prevented potential unexpected interactions ([@bib13]). OC and PIP antibodies are mouse monoclonal IgG1 and were diluted 1:500. As in condition B, PIP did not express tubular structures and was thus used as a negative control. FBXW2 and ARHGAP36 antibodies are polyclonal goat IgG and were diluted 1:100. ARHGAP36 was also used as a negative control. For double immunostaining using EXOSC9, OC and EXOSC9 were stained in different ways to show the difference between OC and EXOSC9 staining ([Fig. 3](#fig3){ref-type="fig"}a). In conditions A, C, D, OC staining was carried out first as the OC outline was very thin. Although previous reports on single immunostaining of OC, EXOSC9, and FBXW2 utilized horseradish peroxidase (HRP) labeling and DAB staining ([@bib2], [@bib3]), we utilized alkaline phosphatase (AP) labeling to improve sensitivity in paraffin sections ([@bib23]). FBXW2 expression was weak and restricted to a specific area immediately after bovine death. In addition, FBXW2 localized between the bone and periosteum with some tubes entering the bone ([Fig. 1](#fig1){ref-type="fig"}b, c). FBXW2 staining subsequently increased after 5 weeks of culture.

Figs. [1](#fig1){ref-type="fig"}a, [3](#fig3){ref-type="fig"}a, and [4](#fig4){ref-type="fig"}a--d show that FBXW2 and OC have similar tubular shapes. Based on the findings of this study, FBXW2 tubes appear to be coated with OC around OC-positive areas ([Fig. 5](#fig5){ref-type="fig"}). The interaction between OC and other proteins, particularly during glucose metabolism, has been studied ([@bib11]; [@bib14], [@bib15]; [@bib17]; [@bib19]; [@bib26]; [@bib28]), whereas the interaction between OC and FBXW2 has not been previously studied. To the author\'s knowledge, this is the first study to reveal an interaction between OC and FBXW2. Future clarification of the roles of OC and FBXW2 in bone regeneration is considered necessary.Fig. 5Hypothesis for OC and FBXW2 co-localization.Fig. 5

5. Conclusions {#sec5}
==============

1.FBXW2 formed tubular structures in the periosteum.2.OC also formed tubular structures and OC and FBXW2 exhibited the same expression pattern.3.FBXW2 tubes were coated with OC.
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